Clinical Trials · NCT02784457

Gonadotropin Releasing Hormone Antagonist in Treatment of Early-onset Severe Ovarian Hyperstimulation Syndrome

CompletedPhase 2Gonadorelin (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
Ain Shams University
Enrollment
84
Start date
Jun 2014
Locations
See registry
Primary endpoint
Number of women who needed culdocentesis or paracentesis of the ascitic fluid
View Gonadorelin compound reference